chr16-20333306-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_003361.4(UMOD):c.*8C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000551 in 1,612,440 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00045 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00056 ( 2 hom. )
Consequence
UMOD
NM_003361.4 3_prime_UTR
NM_003361.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.60
Publications
2 publications found
Genes affected
UMOD (HGNC:12559): (uromodulin) The protein encoded by this gene is the most abundant protein in mammalian urine under physiological conditions. Its excretion in urine follows proteolytic cleavage of the ectodomain of its glycosyl phosphatidylinosital-anchored counterpart that is situated on the luminal cell surface of the loop of Henle. This protein may act as a constitutive inhibitor of calcium crystallization in renal fluids. Excretion of this protein in urine may provide defense against urinary tract infections caused by uropathogenic bacteria. Defects in this gene are associated with the renal disorders medullary cystic kidney disease-2 (MCKD2), glomerulocystic kidney disease with hyperuricemia and isosthenuria (GCKDHI), and familial juvenile hyperuricemic nephropathy (FJHN). Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2013]
UMOD Gene-Disease associations (from GenCC):
- autosomal dominant medullary cystic kidney disease with or without hyperuricemiaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- glomerulocystic kidney disease with hyperuricemia and isosthenuriaInheritance: AD Classification: DEFINITIVE Submitted by: Laboratory for Molecular Medicine
- familial juvenile hyperuricemic nephropathy type 1Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- autosomal dominant medullary cystic kidney disease with hyperuricemiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000453 (69/152256) while in subpopulation AFR AF = 0.000698 (29/41550). AF 95% confidence interval is 0.000498. There are 0 homozygotes in GnomAd4. There are 26 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 69 AD,Unknown gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UMOD | ENST00000396138.9 | c.*8C>T | 3_prime_UTR_variant | Exon 11 of 11 | 5 | NM_003361.4 | ENSP00000379442.5 | |||
UMOD | ENST00000396134.6 | c.*8C>T | 3_prime_UTR_variant | Exon 12 of 12 | 2 | ENSP00000379438.2 | ||||
UMOD | ENST00000570689.5 | c.*8C>T | 3_prime_UTR_variant | Exon 11 of 11 | 5 | ENSP00000460548.1 | ||||
UMOD | ENST00000570331.1 | n.*33C>T | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000454 AC: 69AN: 152138Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
69
AN:
152138
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000325 AC: 81AN: 248888 AF XY: 0.000364 show subpopulations
GnomAD2 exomes
AF:
AC:
81
AN:
248888
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000561 AC: 819AN: 1460184Hom.: 2 Cov.: 30 AF XY: 0.000534 AC XY: 388AN XY: 726250 show subpopulations
GnomAD4 exome
AF:
AC:
819
AN:
1460184
Hom.:
Cov.:
30
AF XY:
AC XY:
388
AN XY:
726250
show subpopulations
African (AFR)
AF:
AC:
22
AN:
33448
American (AMR)
AF:
AC:
14
AN:
44608
Ashkenazi Jewish (ASJ)
AF:
AC:
65
AN:
26098
East Asian (EAS)
AF:
AC:
3
AN:
39672
South Asian (SAS)
AF:
AC:
3
AN:
85874
European-Finnish (FIN)
AF:
AC:
0
AN:
53354
Middle Eastern (MID)
AF:
AC:
0
AN:
5386
European-Non Finnish (NFE)
AF:
AC:
670
AN:
1111418
Other (OTH)
AF:
AC:
42
AN:
60326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
42
84
126
168
210
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000453 AC: 69AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.000349 AC XY: 26AN XY: 74450 show subpopulations
GnomAD4 genome
AF:
AC:
69
AN:
152256
Hom.:
Cov.:
32
AF XY:
AC XY:
26
AN XY:
74450
show subpopulations
African (AFR)
AF:
AC:
29
AN:
41550
American (AMR)
AF:
AC:
8
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5154
South Asian (SAS)
AF:
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
25
AN:
68012
Other (OTH)
AF:
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Kidney disorder Uncertain:1
Dec 12, 2016
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Uncertain:1
-
Martin Pollak Laboratory, Beth Israel Deaconess Medical Center
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.